| 2026-08-05 | 10-Q | 10.3 | Advisory Agreement, dated April 17, 2026, between the Registrant and David Mauro, M.D., Ph.D. |
|---|
| 2026-08-05 | 10-Q | 10.2 | Amended and Restated Advisory Agreement, dated April 30, 2026, between the Registrant and Christopher Gibson, Ph.D. |
|---|
| 2026-08-05 | 10-Q | 10.1 | Outside Director Compensation Policy |
|---|
| 2026-02-25 | 10-K | 10.35 | Sales Agreement dated February 25, 2026 by and between the Registrant and TD Securities (USA), LLC |
|---|
| 2026-02-25 | 10-K | 10.19 | Confirmatory Employment Letter between the Registrant and David Hallett. |
|---|
| 2026-02-25 | 10-K | 10.16 | Employment Offer Letter, dated November 5, 2025, between the Registrant and Dr. Najat Khan, Ph.D. |
|---|
| 2026-02-25 | 10-K | 10.14 | Advisory Agreement dated November 4, 2025 between the Registrant and Christopher Gibson, Ph.D. |
|---|
| 2026-02-25 | 10-K | 10.13 | Outside Director Compensation Policy. |
|---|
| 2025-03-18 | 8-K | 10.1 | Recursion Pharmaceuticals, Inc. Outside Director Compensation Policy. |
|---|
| 2025-02-28 | 10-K | 10.39 | Sales Agreement dated February 28, 2025 by and between the Registrant and Citigroup Capital Markets Inc. |
|---|
| 2025-02-28 | 10-K | 10.36 | Research Collaboration Agreement, dated September 19, 2023, by and between Merck Healthcare KGAA and Exscientia AI Limited. |
|---|
| 2025-02-28 | 10-K | 10.35 | Research Collaboration and Licence Option Agreement, dated June 27, 2016, by and between Sanofi S.A. and Exscientia AI Limited (then named Exscientia Limited). |
|---|
| 2025-02-28 | 10-K | 10.20 | Separation Agreement between the Registrant and Michael Secora. |
|---|
| 2025-02-28 | 10-K | 10.18 | Transition Agreement between the Registrant and Tina Marriott. |
|---|
| 2025-02-28 | 10-K | 10.14 | Confirmatory Employment Letter between the Registrant and Ben Taylor. |
|---|
| 2024-08-28 | 8-K | 10.1 | Irrevocable Undertaking of Evotec SE dated August 28, 2024. |
|---|
| 2024-08-08 | 10-Q | 10.1 | Employment Offer Letter, dated July 1, 2024, between the Registrant and Dr. Najat Khan, Ph.D. |
|---|
| 2024-08-08 | 8-K | 10.3 | Form of Irrevocable Undertaking (Individual). |
|---|
| 2024-08-08 | 8-K | 10.2 | Form of Irrevocable Undertaking (Institutional). |
|---|
| 2024-08-08 | 8-K | 10.1 | Form of Voting and Support Agreement. |
|---|
| 2024-05-09 | 10-Q | 10.2 | Transition Agreement between the Registrant and Shafique Virani |
|---|
| 2024-05-09 | 10-Q | 10.1 | Advisory Agreement between the Registrant and Shafique Virani |
|---|
| 2024-02-29 | 10-K | 10.21 | Amended and Restated Research Collaboration and Option Agreement by and between Bayer AG and the Registrant, dated November 8, 2023. |
|---|
| 2023-11-09 | 10-Q | 10.4 | Master Agreement between the Company and Tempus Labs, Inc dated November 3, 2023. |
|---|
| 2023-08-08 | 10-Q | 10.6 | Open Market Sales Agreement dated August 8, 2023 by and between the Registrant and Jefferies LLC |
|---|
| 2023-08-08 | 10-Q | 10.1 | Employment Offer Letter, dated May 19, 2023, between the Registrant and Dr. David Mauro, M.D., Ph.D. |
|---|
| 2023-07-12 | 8-K | 10.2 | Registration Rights Agreement, dated July 11, 2023, by and among the Company and NVIDIA. |
|---|
| 2023-07-12 | 8-K | 10.1 | Stock Purchase Agreement, dated July 11, 2023, by and among the Company and NVIDIA. |
|---|
| 2023-02-27 | 10-K | 10.8 | Office Lease by and between Vestar Gateway, LLC and Registrant, dated November 13, 2017, as amended through December 2022. |
|---|
| 2023-02-27 | 10-K | 10.3 | 2021 Equity Incentive Plan and forms of agreements thereunder. |
|---|
| 2022-10-25 | 8-K | 10.2 | Registration Rights Agreement, dated October 24, 2022, by and among the Company and the Purchasers. |
|---|
| 2022-10-25 | 8-K | 10.1 | Stock Purchase Agreement, dated October 24, 2022, by and among the Company and the Purchasers. |
|---|
| 2022-08-09 | 10-Q | 10.3 | American Institute of Architects Agreement by and between Engage Contracting Inc. and Registrant dated May 4, 2022. |
|---|
| 2022-08-09 | 10-Q | 10.2 | Office Lease by and between Berrueta Family, L.P. and Registrant, dated July 27, 2015, as amended. |
|---|
| 2022-08-09 | 10-Q | 10.1 | Office Lease by and between Vestar Gateway, LLC and Registrant, dated November 13, 2017, as amended. |
|---|
| 2022-05-10 | 10-Q | 10.2 | Office Lease by and between Constantine Enterprises, Inc and Registrant, dated May 1, 2022. |
|---|
| 2022-05-10 | 10-Q | 10.1 | Office Lease by and between Vestar Gateway, LLC and Registrant, dated November 13, 2017, as amended. |
|---|
| 2022-03-23 | 10-K | 10.25 | Roche Collaboration and License Agreement |
|---|
| 2022-03-23 | 10-K | 10.15 | Lease Agreement by and between Industry Office SLC, LLC and Registrant, dated February 10, 2021, as amended. |
|---|
| 2022-03-23 | 10-K | 10.11 | Bayer Collaboration Expansion Agreement |
|---|
| 2022-03-23 | 10-K | 10.8 | Office Lease by and between Vestar Gateway, LLC and Registrant, dated November 13, 2017, as amended. |
|---|
| 2021-08-13 | 10-Q | 10.3 | Office Lease by and between Vestar Gateway, LLC and Registrant, dated November 13, 2017, as amended. |
|---|
| 2021-05-12 | 10-Q | 10.2 | Equity Exchange Right Agreement dated April 20, 2021 among the Registrant, Christopher Gibson, Ph.D., and the Gibson Family Trust. |
|---|
| 2021-05-12 | 10-Q | 10.1 | Exchange Agreement dated April 20, 2021 among the Registrant, Christopher Gibson, Ph.D., and the Gibson Family Trust. |
|---|